Form 8-K - Current report:
SEC Accession No. 0001104659-25-071746
Filing Date
2025-07-29
Accepted
2025-07-29 16:15:46
Documents
14
Period of Report
2025-07-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2521894d1_8k.htm   iXBRL 8-K 25816
2 EXHIBIT 99.1 tm2521894d1_ex99-1.htm EX-99.1 3540
6 GRAPHIC tm2521894d1_ex99-1img001.jpg GRAPHIC 4913
  Complete submission text file 0001104659-25-071746.txt   202573

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pahc-20250729.xsd EX-101.SCH 3002
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pahc-20250729_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pahc-20250729_pre.xml EX-101.PRE 22350
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2521894d1_8k_htm.xml XML 3751
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 251162069
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)